Early-stage beta
· Errors & gaps may exist · Expanding: US · Nordics · EU
← All companies
/
Top lists
/
Thermo Fisher
Thermo Fisher
2017–2025 · Healthcare
2026-08-11
Overview
Earnings
Margins
Cash flow
Balance
Capital
Plot
USD millions
2017
2018
2019
2020
2021
2022
2023
2024
2025
Revenue
20 918
24 358
25 542
32 218
39 211
44 915
42 857
42 879
44 556
Operating profit (EBIT)
2 968
3 783
4 594
7 794
10 028
8 393
6 859
7 337
7 746
Net income attributable to shareholders
2 225
2 938
3 696
6 375
7 725
6 950
5 995
6 335
−10 279
EBIT margin
14,2%
15,5%
18,0%
24,2%
25,6%
18,7%
16,0%
17,1%
17,4%
Operating cash flow
4 006
4 543
4 973
8 289
9 312
9 154
8 406
8 667
7 818
Free cash flow
3 498
3 785
4 047
6 815
6 789
6 911
6 927
7 267
6 293
Cash
786
1 335
2 103
10 325
4 477
8 524
8 077
4 009
9 852
Interest-bearing debt
—
—
17 752
—
34 870
34 488
34 917
31 275
39 385
0
20 000
40 000
60 000
0,0%
10,0%
20,0%
30,0%
2017
2018
2019
2020
2021
2022
2023
2024
2025
20 918
24 358
25 542
32 218
39 211
44 915
42 857
42 879
44 556
2 968
3 783
4 594
7 794
10 028
8 393
6 859
7 337
7 746